期刊文献+

卡马西平对癫痫患者血同型半胱氨酸、叶酸、维生素B_(12)水平的影响 被引量:9

Effect of carbamazepine on the levels of homocysteine, folic acid, vitamin B_(12) in patients with epilepsy
在线阅读 下载PDF
导出
摘要 目的探讨卡马西平(Carbamazepine,CBZ)对血同型半胱氨酸(Homocysteine,Hcy)、叶酸、维生素B12(vitaminB12,VitB12)水平的影响。方法分别检测CBZ单药治疗癫痫患者(CBZ组)的血Hcy、叶酸、VitB12水平,并与未服用抗癫痫药的患者(癫痫对照组)及健康对照组进行比较。结果 CBZ组患者血Hcy水平明显高于癫痫对照组和正常对照组(P<0.01),叶酸水平低于癫痫对照组和正常对照组(P<0.05),VitB12水平有下降趋势,但与两对照组比较,差异无统计学意义(P>0.05)。结论 CBZ可引起癫痫患者血Hcy水平升高和叶酸水平降低;长期服用CBZ的癫痫患者应监测血Hcy、叶酸、VitB12浓度,及时补充叶酸和B族维生素,以预防血栓事件的发生。 Objective To investigate the effect of carbamazepine (CBZ) on the levels of homocysteine (Hey), folio acid, vitamin BI~ (VitBi2). Methods The levels of blood Hey, folio acid, VitB12 were measured in epilepsy patients treated by CBZ (CBZ group), epilepsy patients not treated by CBZ (the epilepsy control group), healthy individuals (the normal control group). The results were compared between the three groups. Results The blood Hey levels in CBZ group were significantly higher than those in the epilepsy control group and the normal control group (P〈0.01), while the levels of folic acid were significantly lower (P〈0.05). The levels of VitB12 exhibited a downward trend in CBZ group, but showed no statistically significant difference with the other two groups. Conclusion CBZ can elevate the levels of Hcy and reduce the level of folic acid in patients with epilepsy. Epilepsy patients taking CBZ for a long time should be monitored for the levels of blood Hey, folio acid, VitB12 and timely supplemented with folic acid and B vitamins in order to prevent the occurrence of thromboembolic events.
出处 《海南医学》 CAS 2013年第1期11-12,共2页 Hainan Medical Journal
关键词 卡马西平 癫痫 同型半胱氨酸 叶酸 维生素B Carbamazepine Epilepsy Homocysteine Folic acid Vitamin B12
  • 相关文献

参考文献1

二级参考文献16

  • 1邢红霞,彭海.同型半胱氨酸对离体帕金森模型的作用及其机制的研究[J].脑与神经疾病杂志,2004,12(4):267-270. 被引量:3
  • 2张微微.钙通道阻滞剂在认知障碍防治中的应用[J].国外医学(脑血管疾病分册),2005,13(9):686-688. 被引量:3
  • 3Frosst P,Blom HJ,Milos R,et al.A candidate genetic risk factor for vascular disease:a common mutation in methylenetetrahydrofolate reductase[J].Nat Genet,1995,10(1):111-113.
  • 4McCuily KS.Vascular pathology of henaocysteinemia:implications for the pathogenesis of arteriosclerosis[J].Am J Pathol,1969,56(1):111-128.
  • 5Moller J,Nielsen GM,Tvedegeard KC,et al.A meta-analysis of cerebrovascular disease and hyperhomocysteinemia[J].Scand J Clin Lab Invest,2000,60(6):491-500.
  • 6Wald DS,Law M,Morris JK.Homocysteine and cardiovascular disease:evidence on causality from a meta analysis[J].BMJ,2002,325(7374):1202-1206.
  • 7Toole JF,Malinow MR,Chambless LE,et al.Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke,myocardial infarction,and death:the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial[J].JAMA,2004,291(5):565-575.
  • 8Seshadri S,Beiser A,Selhub J,et al.Plasma homocysteine as a risk factor for dementia and Alzheimer's disease[J].N Engl J Med,2002,346(7):476-483.
  • 9Prins ND,Den Heijer T,Hofinan A,et al.Homocysteine and cognitive function in the elderly:the Rouerdam Scan Study[J].Neurology,2002,59(9):1375-1380.
  • 10Ravaglia G,Forti P,Maioli F,et al.Homocysteine and cognitive perforance in healthy elderly subjects[J].Arch Gemntol Geriatr Suppl,2004,(9):349-357.

共引文献14

同被引文献133

引证文献9

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部